Cargando…

Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice

OBJECTIVE: Intraplaque neovascularization is an important feature of unstable human atherosclerotic plaques. However, its impact on plaque formation and stability is poorly studied. Because proliferating endothelial cells generate up to 85% of their ATP from glycolysis, we investigated whether pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrotta, Paola, Van der Veken, Bieke, Van Der Veken, Pieter, Pintelon, Isabel, Roosens, Laurence, Adriaenssens, Elias, Timmerman, Vincent, Guns, Pieter-Jan, De Meyer, Guido R.Y., Martinet, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176341/
https://www.ncbi.nlm.nih.gov/pubmed/32188275
http://dx.doi.org/10.1161/ATVBAHA.119.313692
_version_ 1783524999788756992
author Perrotta, Paola
Van der Veken, Bieke
Van Der Veken, Pieter
Pintelon, Isabel
Roosens, Laurence
Adriaenssens, Elias
Timmerman, Vincent
Guns, Pieter-Jan
De Meyer, Guido R.Y.
Martinet, Wim
author_facet Perrotta, Paola
Van der Veken, Bieke
Van Der Veken, Pieter
Pintelon, Isabel
Roosens, Laurence
Adriaenssens, Elias
Timmerman, Vincent
Guns, Pieter-Jan
De Meyer, Guido R.Y.
Martinet, Wim
author_sort Perrotta, Paola
collection PubMed
description OBJECTIVE: Intraplaque neovascularization is an important feature of unstable human atherosclerotic plaques. However, its impact on plaque formation and stability is poorly studied. Because proliferating endothelial cells generate up to 85% of their ATP from glycolysis, we investigated whether pharmacological inhibition of glycolytic flux by the small-molecule 3PO (3-[3-pyridinyl]-1-[4-pyridinyl]-2-propen-1-one) could have beneficial effects on plaque formation and composition. APPROACH AND RESULTS: ApoE(−/)(−) (apolipoprotein E deficient) mice treated with 3PO (50 µg/g, ip; 4×/wk, 4 weeks) showed a metabolic switch toward ketone body formation. Treatment of ApoE(−/−)Fbn1(C1039G+/−) mice with 3PO (50 µg/g, ip) either after 4 (preventive, twice/wk, 10 weeks) or 16 weeks of Western diet (curative, 4×/wk, 4 weeks) inhibited intraplaque neovascularization by 50% and 38%, respectively. Plaque formation was significantly reduced in all 3PO-treated animals. This effect was independent of intraplaque neovascularization. In vitro experiments showed that 3PO favors an anti-inflammatory M2 macrophage subtype and suppresses an M1 proinflammatory phenotype. Moreover, 3PO induced autophagy, which in turn impaired NF-κB (nuclear factor-kappa B) signaling and inhibited TNF-α (tumor necrosis factor-alpha)–mediated VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) upregulation. Consistently, a preventive 3PO regimen reduced endothelial VCAM-1 expression in vivo. Furthermore, 3PO improved cardiac function in ApoE(−/−)Fbn1(C1039G+/−) mice after 10 weeks of treatment. CONCLUSIONS: Partial inhibition of glycolysis restrained intraplaque angiogenesis without affecting plaque composition. However, less plaques were formed, which was accompanied by downregulation of endothelial adhesion molecules—an event that depends on autophagy induction. Inhibition of coronary plaque formation by 3PO resulted in an overall improved cardiac function.
format Online
Article
Text
id pubmed-7176341
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-71763412020-05-04 Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice Perrotta, Paola Van der Veken, Bieke Van Der Veken, Pieter Pintelon, Isabel Roosens, Laurence Adriaenssens, Elias Timmerman, Vincent Guns, Pieter-Jan De Meyer, Guido R.Y. Martinet, Wim Arterioscler Thromb Vasc Biol Basic Sciences OBJECTIVE: Intraplaque neovascularization is an important feature of unstable human atherosclerotic plaques. However, its impact on plaque formation and stability is poorly studied. Because proliferating endothelial cells generate up to 85% of their ATP from glycolysis, we investigated whether pharmacological inhibition of glycolytic flux by the small-molecule 3PO (3-[3-pyridinyl]-1-[4-pyridinyl]-2-propen-1-one) could have beneficial effects on plaque formation and composition. APPROACH AND RESULTS: ApoE(−/)(−) (apolipoprotein E deficient) mice treated with 3PO (50 µg/g, ip; 4×/wk, 4 weeks) showed a metabolic switch toward ketone body formation. Treatment of ApoE(−/−)Fbn1(C1039G+/−) mice with 3PO (50 µg/g, ip) either after 4 (preventive, twice/wk, 10 weeks) or 16 weeks of Western diet (curative, 4×/wk, 4 weeks) inhibited intraplaque neovascularization by 50% and 38%, respectively. Plaque formation was significantly reduced in all 3PO-treated animals. This effect was independent of intraplaque neovascularization. In vitro experiments showed that 3PO favors an anti-inflammatory M2 macrophage subtype and suppresses an M1 proinflammatory phenotype. Moreover, 3PO induced autophagy, which in turn impaired NF-κB (nuclear factor-kappa B) signaling and inhibited TNF-α (tumor necrosis factor-alpha)–mediated VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) upregulation. Consistently, a preventive 3PO regimen reduced endothelial VCAM-1 expression in vivo. Furthermore, 3PO improved cardiac function in ApoE(−/−)Fbn1(C1039G+/−) mice after 10 weeks of treatment. CONCLUSIONS: Partial inhibition of glycolysis restrained intraplaque angiogenesis without affecting plaque composition. However, less plaques were formed, which was accompanied by downregulation of endothelial adhesion molecules—an event that depends on autophagy induction. Inhibition of coronary plaque formation by 3PO resulted in an overall improved cardiac function. Lippincott Williams & Wilkins 2020-05 2020-03-19 /pmc/articles/PMC7176341/ /pubmed/32188275 http://dx.doi.org/10.1161/ATVBAHA.119.313692 Text en © 2020 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Basic Sciences
Perrotta, Paola
Van der Veken, Bieke
Van Der Veken, Pieter
Pintelon, Isabel
Roosens, Laurence
Adriaenssens, Elias
Timmerman, Vincent
Guns, Pieter-Jan
De Meyer, Guido R.Y.
Martinet, Wim
Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice
title Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice
title_full Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice
title_fullStr Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice
title_full_unstemmed Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice
title_short Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice
title_sort partial inhibition of glycolysis reduces atherogenesis independent of intraplaque neovascularization in mice
topic Basic Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176341/
https://www.ncbi.nlm.nih.gov/pubmed/32188275
http://dx.doi.org/10.1161/ATVBAHA.119.313692
work_keys_str_mv AT perrottapaola partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT vandervekenbieke partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT vandervekenpieter partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT pintelonisabel partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT roosenslaurence partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT adriaenssenselias partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT timmermanvincent partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT gunspieterjan partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT demeyerguidory partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice
AT martinetwim partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice